Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
Keep An Eye On Earnings Reports
March 20, 2025 11:32 AM 2 min read

Caleres Reports Lower Q4 Sales, Cautious Outlook For 2025 Amid Inflation And Tariffs

by Lekha Gupta Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Caleres, Inc. (NYSE:CAL) shares are trading higher after the company reported fourth-quarter results.

Revenues fell 8.3% year over year to $639.2 million, missing the analyst consensus of $653.86 million.

Famous Footwear sales fell 9.6% Y/Y, with comparable store sales down 2.9%. Brand Portfolio sales decreased 7.2% in the quarter.

“Famous Footwear’s business softened in the quarter, but we maximized key selling periods. We invested to support our long-term growth while continuing to evolve our supply chain and further mitigate the impact of additional tariffs,” said Jay Schmidt, president and chief executive officer.

The company’s gross margin rate contracted 80 basis points year over year to 43.0% and adjusted EBITDA fell to $29.0 million.

Adjusted EPS of 33 cents beat the consensus of 24 cents.

In 2024, Caleres returned $74.7 million in cash to shareholders through dividends and share repurchases. Borrowings under the revolving credit facility totaled $219.5 million at the end of the period.

“As we look forward to 2025 and the macroeconomic environment with persistent inflation and newer tariffs, we believe it is prudent to take a conservative view for the year,” added Schmidt.

Outlook: The company expects FY25 net sales to decline by 1% to up 1% and EPS of $2.80 – $3.20 (consensus $3.21).

For the first quarter, Caleres expects sales to decline 5% – 6% and EPS of $0.35 – $0.40 vs. consensus of $0.87.

Caleres said it currently expects 75% of its Brand Portfolio, and an even greater percentage of Lead Brands’ sourcing to be outside of China by the second half of 2025.

Price Action: CAL shares are down 2.46% at $15.99 at the last check Thursday.

Read Next:

  • Temu Parent PDD Holdings Drops After Q4 Revenue Miss: Details

Image via Shutterstock.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsEquitiesNewsGuidanceSmall CapTop StoriesBriefsStories That Matter
CAL Logo
CALCaleres Inc
$11.60-%
Overview
TPR Logo
TPRTapestry Inc
$153.990.87%

Last month, the company inked a deal to acquire Stuart Weitzman from Tapestry for $105 million. The guidance excludes this acquisition, which is expected to close in the summer of 2025.

CAL Logo
CALCaleres Inc
$11.60-%
Overview
TPR Logo
TPRTapestry Inc
$153.990.87%
Comments
Loading...